Empowering the Voice of Kansas Pharmacy

Log in

Latest News

Pharmacy News & Notes

Share your news with KPhA! Submit an announcement.

  • 03/04/2020 10:48 AM | Anonymous member (Administrator)

    Are you a new practitioner looking for an opportunity to continue your involvement in KPhA? We have a home for you on the Kansas New Practitioner Network Committee!

    We understand that New Practitioner's availability can vary greatly by member and have tailored commitments to our members needs. Participate in a short-term "Burst" project, a longitudinal low time commitment task or something in-between. The purpose of KNPN is to support and to guide new practitioners the first five years after graduation in their transition from student to successful new practitioner, and beyond.

    Together KNPN helps final year students and new graduates discover opportunities in pharmacy, develop themselves and their professional network, and define the future of their profession and career. If this sounds like a good fit for you please complete the KNPN Committee interest form: https://forms.gle/8VewRHmMpn1hzxgj6

  • 03/04/2020 10:26 AM | Anonymous member (Administrator)

    By Don R. McGuire Jr., R.Ph., J.D.
    Pharmacists Mutual Insurance Company

    The opioid crisis has brought a lot of attention to the prescribing and dispensing of opioids. This attention has also extended to the prescribing and dispensing of all controlled substances. I recently attended a seminar which contained a number of sessions on opioids and controlled substances. One of these sessions suggested that every pharmacist should read the DEA's Pharmacist's Manual1. That suggestion caused me to ask myself when was the last time I had read it. One human trait is that we tend to forget details over time and our memory becomes a little less sharp. There have been a number of times when I was sure what a contract provision said, only to go back, read the document, and find that what it stated was slightly different from my memory. This same phenomenon applies to the Pharmacist's Manual. The manual is about 80 pages, but it is much more readable than the actual statute and regulations.

    The speaker at the seminar explained that many pharmacists feel their duty is to make sure that a controlled substance prescription isn't forged or altered. While that is true, the duty is much broader. For a controlled substance prescription to be valid, it must be issued for a legitimate medical purpose in the usual course of the prescriber's professional practice. The law does not require a pharmacist to dispense a questionable prescription. The DEA has provided some red flags that may indicate diversion. Those are discussed in 2018 decision and order2. Corresponding Responsibility is a topic that requires its own forum so I won't delve more deeply into it now.

    The Pharmacist's Manual contains information on a number of topics. Besides a basic introduction to the Schedules, there is a lot of practical information in the manual. There is a section on the transfer and disposal of controlled substances. This covers transfer to another pharmacy, the original manufacturer, or a reverse distributor. There are numerous reminders to use the triplicate DEA Form 222 to transfer Schedule II substances. Another reason to refresh our memories periodically is that requirements change and if we rely only on our memories, we may not be current. The DEA recently announced the phase out of the triplicate form over the next two years.

    The DEA Form 222 is also mentioned in the section of the manual on ordering of controlled substances. Topics here include how to order the Form 222, who is authorized to sign the forms, and what to do if the forms are lost or stolen. The manual also contains useful information on what to do when controlled substances are stolen or lost. The DEA must be notified, in writing, within one business day of the discovery of the theft or loss. Completion of the DEA Form 106 in this situation can be made easier by using the biennial inventory and prescription records because you can use these records to determine how much product was stolen or lost. There is also an entire section of recordkeeping requirements. While many pharmacies are using a perpetual inventory system today, that does not replace the required biennial inventories. Physical inventories are required for a new registrant (either opening a new pharmacy or taking over an existing one) and for products that are newly added to a schedule.

    The manual also contains helpful information for the review and dispensing of controlled substance prescriptions. It provides what information is required to be on the prescription itself and the information required to be on the prescription label. Partial fill situations are addressed as is the dispensing of controlled substances without a prescription. The record of over the counter sales of controlled substances is required to be kept in a bound record book. These types of sales must be made by a pharmacists and cannot be delegated to a non-pharmacist. While the manual contains a lot of practical information, there are some uncommon provisions also. Sometimes these less common situations are problem-prone because we aren't as familiar with the situation. Suppose one of your patients has a valid prescription for a C-IV medication and requests that you send a refill to their vacation home in Bermuda. Can you send that refill to a foreign country? Not unless you are registered with the DEA as an exporter and have obtained the necessary permits or submitted the necessary declarations for export. The pharmacist might assume it is permissible to send the refill because there is a valid prescription on file. This is an example where a seemingly reasonable conclusion is incorrect.

    The periodic review of the DEA's Pharmacist's Manual is a good risk management tool. During my years of practice, none of my employers recommended or required that I review it. My working knowledge of the DEA regulations was what I drew from my pharmacy law class and any updates that I may have read and retained. Given the scrutiny that is currently being given to the dispensing of controlled substances, an annual review of the Pharmacist's Manual is an excellent risk management tool to help the pharmacist and pharmacy avoid a potential problem brought on by foggy memory of the requirements. In addition, a review of your state statutes and regulations should also be done because your state may have more restrictive standards which you are required to follow.

    References
    https://www.deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm_manual.pdf
    https://www.deadiversion.usdoj.gov/fed_regs/actions/2018/fr0220_4.pdf#search=red%20flag%20diversion

    This series, Pharmacy and the Law, is presented by Pharmacists Mutual Insurance Company and your State Pharmacy Association through Pharmacy Marketing Group, Inc., a company dedicated to providing quality products and services to the pharmacy community.

    © Don R. McGuire Jr., R.Ph., J.D., is General Counsel, Senior Vice President, Risk Management & Compliance at Pharmacists Mutual Insurance Company.

    This article discusses general principles of law and risk management. It is not intended as legal advice. Pharmacists should consult their own attorneys and insurance companies for specific advice. Pharmacists should be familiar with policies and procedures of their employers and insurance companies, and act accordingly.

  • 03/02/2020 10:41 AM | Anonymous member (Administrator)

    Pharmacy wasn't Tessa Schnelle's first choice for a career. "Pharmacy is actually a second career for me," she said.

    Previously, Schnelle worked in human resources. She was exposed to pharmacy through hiring pharmacists and technicians. "I had always planned to pursue a career in healthcare and planned to obtain a master's in counseling, but after spending time with my pharmacy staff and observing the impact of the pharmacist on their patients, I decided to change directions and pursue a career in pharmacy."

    Schnelle is a P4 at the University of Kansas School of Pharmacy. Originally from Center Point, IA, she now resides in Louisburg, KS, with her family -- husband, Derick, and sons, Dayton, Denver and Dallas. After graduation in May, she plans to pursue a residency focused in the areas of ambulatory care, business administration and psychiatric medicine.

    She draws inspiration from a variety of sources, but Melinda Gates currently is at the top of the list. "I love the work that Melinda does abroad for women's health and gender equality," she said. "A few years back I got the pleasure to hear Melinda speak and was so impressed with her passion and impact globally that I researched careers with the Gates Foundation. I'm sure they could find use for a pharmacist on their team right?"

    The best advice she has been given is "People will forget what you said, but they will never forget how you made them feel," she said. "Over the years, expressing gratitude and recognizing others for their contributions has become one of my personal disciplines. This practice has shaped and changed the teams that I am a part of. When people feel valued the sky is the limit on what you can accomplish together."

    As for students just getting started in pharmacy school, she offers this advice: "Building your CV should not be a box checking exercise," she said. "Try something new and take risks; find a cause that gives you meaning and purpose and get involved beyond the surface level. Never underestimate the power of building your personal brand and professional network as a student."

  • 02/19/2020 10:36 AM | Anonymous member (Administrator)

    A group of six proponents of HB 2598 provided testimony in front of the House Insurance Committee on Monday, Feb. 17. The six conferees focused heavily on the financial and clinical burden that predatory PBM practices have on patients, physicians and pharmacists.

    "We're excited about the response from the committee and grateful for their attention and thoughtful questions," said Matt Morrison, KPhA President.

    On Wednesday, Feb. 19, opponents of HB 2598 will get an opportunity to speak regarding the bill. After their testimony, KPhA will be provided an opportunity to rebut their statements. "We are cautiously optimistic about the chances that this bill clears the committee but the fight is definitely not over," Morrison added.

    KPhA Day with the Legislature will take place on Tuesday, Feb. 25. Register Now!

    In the photo, from left: Emily Scheck, Amanda Applegate, Aaron Dunkel, Dared Price, Sam Boyajian, Nate Rockers, Matt Morrison and Julie Hein.

  • 02/19/2020 10:34 AM | Anonymous member (Administrator)

    Members of the Kansas New Practitioners Network (KNPN) are asking KPhA members for their thoughts on a few questions important to new practitioners. Answers will be collected and provided to KNPN to share with members and students. A new set of three questions will be available for the next six months.

    1. What are residency interviews like?
    2. When you transitioned from graduation to the workforce, what was it like finding sufficient work?
    3. How do you know if you’re “too good’ for a job?

    Take the Survey

  • 02/19/2020 10:32 AM | Anonymous member (Administrator)

    All APhA members need to know about a crucial effort by APhA, the National Community Pharmacists Associations (NCPA), Arkansas Pharmacists Association (APA), the National Alliance of State Pharmacy Associations (NASPA), and other pharmacy organizations: In the next few weeks, we will jointly submit an amicus curiae brief to the Supreme Court in Rutledge v. the Pharmaceutical Care Management Association.

    In this case, the state of Arkansas will argue to allow the state to regulate pharmacy benefit managers (PBMs), which some lower courts have said is forbidden by federal law. If the Supreme Court rules in favor of Arkansas, states with PBM oversight laws similar to those of Arkansas would have clearer authority to regulate PBMs.

    “Amicus curiae” literally translates to “friend of the court” and refers to legal briefs submitted by entities who are not party to the case at hand—APhA will not have any direct role in arguing the case. But, at the discretion of the Court, the justices can review amicus briefs to get more insight and expert opinion that could have bearing on the case.

    Read more a www.pharmacist.com.

  • 02/18/2020 1:26 PM | Anonymous member (Administrator)

    It may not sound enticing, but creating a will puts power in your hands.

    According to the global analytics firm Gallup, only about 44 percent of Americans have created a will. This finding may not surprise you. After all, no one wants to be reminded of their mortality or dwell on what might happen upon their death, so writing a last will and testament is seldom prioritized on the to-do list of a Millennial or Gen Xer. What may surprise you, though, is the statistic cited by personal finance website The Balance: around 35 percent of Americans aged 65 and older lack wills.1,2

    A will is an instrument of power. By creating one, you gain control over the distribution of your assets. If you die without one, the state decides what becomes of your property, with no regard to your priorities. A will is a legal document by which an individual or a couple (known as “testator”) identifies their wishes regarding the distribution of their assets after death. A will can typically be broken down into four parts:

    • Executors: Most wills begin by naming an executor. Executors are responsible for carrying out the wishes outlined in a will. This involves assessing the value of the estate, gathering the assets, paying inheritance tax and other debts (if necessary), and distributing assets among beneficiaries. It is recommended that you name an alternate executor in case your first choice is unable to fulfill the obligation. Some families name multiple children as co-executors, with the intention of thwarting sibling discord, but this can introduce a logistical headache, as all the executors must act unanimously.2,3
    • Guardians: A will allows you to designate a guardian for your minor children. The designated guardian you appoint must be able to assume the responsibility. For many people, this is the most important part of a will. If you die without naming a guardian, the courts will decide who takes care of your children.
    • Gifts: This section enables you to identify people or organizations to whom you wish to give gifts of money or specific possessions, such as jewelry or a car. You can also specify conditional gifts, such as a sum of money to a young daughter, but only when she reaches a certain age.
    • Estate: Your estate encompasses everything you own, including real property, financial investments, cash, and personal possessions. Once you have identified specific gifts you would like to distribute, you can apportion the rest of your estate in equal shares among your heirs, or you can split it into percentages. For example, you may decide to give 45 percent each to two children and the remaining 10 percent to your sibling.

    A do-it-yourself will may be acceptable, but it may not be advisable. The law does not require a will to be drawn up by a professional, so you could create your own will, with or without using a template. If you make a mistake, however, you will not be around to correct it. When you draft a will, consider enlisting the help of a legal, tax, or financial professional who could offer you additional insight, especially if you have a large estate or a complex family situation.

    Remember, a will puts power in your hands. You have worked hard to create a legacy for your loved ones. You deserve to decide how that legacy is sustained.

    Citations.
    1 - https://news.gallup.com/poll/191651/majority-not.aspx [4/24/18]
    2 - https://www.thebalance.com/wills-4073967 [4/24/18]
    3 - https://www.nolo.com/legal-encyclopedia/naming-more-one-executor.html [12/3/18]

    This series, Financial Forum, is presented by PRISM Wealth Advisors, LLC and your State Pharmacy Association through Pharmacy Marketing Group, Inc., a company dedicated to providing quality products and services to the pharmacy community.

    Pat Reding and Bo Schnurr may be reached at 800-288-6669 or pbh@berthelrep.com. Registered Representative of and securities and investment advisory services offered through Berthel Fisher & Company Financial Services, Inc. Member FINRA/SIPC. PRISM Wealth Advisors LLC is independent of Berthel Fisher & Company Financial Services Inc.

    This material was prepared by MarketingLibrary.Net Inc., and does not necessarily represent the views of the presenting party, nor their affiliates. All information is believed to be from reliable sources; however we make no representation as to its completeness or accuracy. Please note - investing involves risk, and past performance is no guarantee of future results. The publisher is not engaged in rendering legal, accounting or other professional services. If assistance is needed, the reader is advised to engage the services of a competent professional. This information should not be construed as investment, tax or legal advice and may not be relied on for the purpose of avoiding any Federal tax penalty. This is neither a solicitation nor recommendation to purchase or sell any investment or insurance product or service, and should not be relied upon as such. All indices are unmanaged and are not illustrative of any particular investment.

  • 01/13/2020 2:41 PM | Anonymous member (Administrator)

    Kansas has now joined most of the rest of the continental United States as reporting widespread influenza activity, according to the Weekly Influenza Surveillance Report from the Centers for Disease Control and Prevention. Kansas pharmacists should continue to encourage patients to get their flu shots even though we are well into flu season. The flu vaccination is always the best way to prevent flu and its potentially serious complications.

    The CDC report notes key indicators that track flu activity remain high, but indicators that track severity (hospitalizations and deaths) are not high at this point in the season. Visits to health care providers for influenza-like illness has descreased slightly, but hospitalizations increased. The percentage of deaths attributed to pneumonia and influenza is 5.8 percent, which is below the epidemic threshold. Five new pediatric deaths were reported, bringing the seasonal total to 32.

    CDC estimates that so far this season there have been at least 9.7 million flu illnesses, 87,000 hospitalizations and 4,800 deaths from flu.

    See the full report.

  • 01/11/2020 10:00 AM | Anonymous member (Administrator)

    ALEXANDRIA, Va. — The country’s largest organization of independent pharmacists cheered the U.S. Supreme Court’s recent decision to hear an Arkansas case to decide whether ERISA preempts (supersedes) a state law that regulates pharmacy benefit managers – massive corporate middlemen who have operated in a regulatory no-man’s land for decades.

    “Pharmacy benefit managers have virtually no oversight, and as a result they behave like monopolies,” said B. Douglas Hoey, pharmacist, MBA, CEO of the National Community Pharmacists Association. “Not only have PBMs failed to manage the cost of prescription drugs, which is why they were created, but they are inflating prices for patients and destroying local pharmacies.”

    NCPA has been fighting to rein in PBMs for years. NCPA pushes for state laws that would end PBM abuses such as spread pricing and gag clauses that cause patients’ insurance premiums and prescription out-of-pocket costs to soar. The latest battle comes from a case in Arkansas, where the state was blocked by a lower court ruling from enforcing Act 900, a law that effectively prohibits PBMs from reimbursing pharmacies below the pharmacies’ cost to acquire the medication and includes provisions that would disclose to consumers and plans the hidden profit motives of PBMs.

    NCPA together with the Arkansas Pharmacists Association filed a brief supporting the state before the U.S. Court of Appeals for the Eighth Circuit, and will file a similar brief before the U.S. Supreme Court.

    “This is an important moment for community pharmacies,” said Hoey. “There’s strong bipartisan agreement in the states that PBM behavior is out of control. The U.S. is the only country in the world that has turned over the management of prescription drugs to PBMs and the U.S. has the highest drug costs in the world. We don’t think that is coincidence.”

    At issue is the extent to which the federal Employee Retirement Income Security Act of 1974 (ERISA), which regulates private employee benefit plans, preempts the states from regulating the amount that PBMs pay pharmacies to dispense prescription drugs that are covered by an employer-sponsored health plan. The PBMs, which are among the richest corporations in the world, say even though they are not liable as fiduciaries under ERISA, that statute shields them from state regulation when they are servicing an employer-sponsored plan.

    “ERISA doesn’t shelter the practices of PBMs,” said Hoey. “We’re very optimistic that the Supreme Court will agree that PBMs do not get to act with impunity from state and federal law.”

    The Court will likely hear oral arguments in early spring. It will render a decision before the end of June, which marks the end of the Court’s current term.

  • 01/10/2020 2:45 PM | Anonymous member (Administrator)

    Inject some pharmacy-filled energy in to the Kansas State Capitol on Feb. 5 as KPhA engages in face-to-face grassroots advocacy during its annual Day with the Legislature.

    Help KPhA pack the statehouse with pharmacists, pharmacy students and technicians. Even if you can't attend for the full day, your presense matters as we work to educate policy makers on important issues facing the profession. Let's show Kansas lawmakers "Pharmacists Can Do It!" and that you are highly trained and skilled members of your patients' health care team.

    Register Today!

KPhA appreciates the generous support provided by

Diamond Corporate Members
Silver Corporate Members
Bronze Corporate Members
Compliant Pharmacy Alliance
PBA Health
Pharmacists Mutual







Kansas Pharmacists
Association

Preserving, protecting and advancing Kansas pharmacy practice through education, engagement and advocacy.

Contact Us

  • 1020 SW Fairlawn Road
    Topeka, KS 66604
  • 785.228.2327
  • info@ksrx.org
Powered by Wild Apricot Membership Software